Landmark analyses showed that 3-year event-free survival was significantly improved for women who achieved pathological complete response compared with those who did not ( HR 038 , 95 % CI 022-063 , p = 00003 ) , as was 3-year overall survival ( 035 , 015-070 , p = 0005 ) .